Estimating surgery, radiotherapy and systemic anti-cancer therapy treatment costs for cancer patients by stage at diagnosis [0.03%]
估计癌症患者诊断时的手术、放疗和系统抗癌治疗费用
Lorna Wills,Diana Nagarwalla,Clare Pearson et al.
Lorna Wills et al.
Background: The increasing burden of cancer has economic implications for the healthcare system in England. However, there is limited evidence on the cost of cancer treatment. We calculated the costs of initial cancer tre...
Manuel Denzer,Philipp Grunau
Manuel Denzer
Using a novel German linked employer-employee dataset, we provide unique evidence about the consequences of working from home (WfH) on individual health and well-being. During the recent pandemic, this locational flexibility measure has bee...
Length of hospital stays and financial incentives: evidence from Dutch rehabilitation centers [0.03%]
住院时间与财政激励：荷兰康复中心的经验
Katalin Gaspar,Ramsis Croes,Misja Mikkers et al.
Katalin Gaspar et al.
Non-linear reimbursement contracts in healthcare have been increasingly used to quantify providers' responses to financial incentives. In the present research, we utilize a large one-off increase in the reimbursement of rehabilitation care ...
Losses of lifetime employment duration and productivity for patients with different subtypes and stages of lung cancer [0.03%]
不同亚型及分期的肺癌患者的终身就业时长损失和劳动能力减损估测
Szu-Chun Yang,Wu-Wei Lai,Tzu-I Wu et al.
Szu-Chun Yang et al.
Background: How different subtypes and stages of lung cancer affect morbidity- and mortality-associated productivity have not been investigated. This study quantified the losses of lifetime employment duration and product...
Bruno Wichmann,Roberta Moreira Wichmann
Bruno Wichmann
We develop a nonparametric model to study health spillover effects of policy interventions. We use double/debiased machine learning to estimate the model using data from 74 hospitals in Rio de Janeiro, Brazil, and examine cross-patient spil...
Zuleika Ferre,Patricia Triunfo,José-Ignacio Antón
Zuleika Ferre
Abundant evidence has tracked the labour market and health assimilation of immigrants, including static analyses of differences in how foreign-born and native-born residents consume health care services. However, we know much less about how...
Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland [0.03%]
芬兰HER2阳性不可切除和/或转移性乳腺癌患者二线接受德鲁替斯单抗治疗的成本效益模型
Jeroen H J Paulissen,Ahmed H Seddik,Kyle J Dunton et al.
Jeroen H J Paulissen et al.
Objectives: Trastuzumab deruxtecan (T-DXd) was recently recommended by the Committee for Medicinal Products for Human Use as a treatment for adult patients with unresectable or metastatic HER2-positive breast cancer, who ...
Disclosing the 'Big C': what does cancer survivorship signal to employers? [0.03%]
"大C"的披露：癌症幸存者向雇主传递了什么信息？
Philippe Sterkens,Adelina Sharipova,Stijn Baert
Philippe Sterkens
To study hiring discrimination against cancer survivors, we conduct a vignette experiment in which American and British professionals recruited via Prolific evaluate fictitious job candidates. Candidates differed by periods of non-employmen...
Scales and size-quality outcomes in adult learning disability residential care: evidence from the UK [0.03%]
规模与质量：来自英国成人学习障碍寄宿护理的证据
Chelsea Chunwen Xiao,Nikita Makarchev,Xin Tao
Chelsea Chunwen Xiao
Residential care services are under increasing pressure to lower service provision costs while maintaining quality of care. Using a translog cost function, this paper examines the relationship between cost, quality and output in England's l...
Factors associated with the author-reported cost-effectiveness threshold in high-income countries: systematic review and multivariable modelling [0.03%]
高收入国家作者报告的成本效益门槛的相关因素：系统综述与多变量建模
Nicolas Boespflug,Jérôme Wittwer,Antoine Bénard
Nicolas Boespflug
Objective: The cost-effectiveness threshold (CET) is a key parameter to guide objective reimbursement decisions, yet very few countries have defined a reference CET, and there is no reference method for defining it. Our o...